Edit |   |
---|---|
Antigenic Specificity | RSV, Respiratory syncytial Virus (Palivizumab biosimilar) |
Clone | Palivizumab |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-RSV Recombinant Antibody (Palivizumab). Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. |
Immunogen | n/a |
Other Names | Anti-RSV Recombinant Antibody, Research Grade Palivizumab, Anti-RSV Recombinant Antibody(Palivizumab), MEDI-493, Antibody Drug Analogues, Monoclonal Antibody, YR1036, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 188039-54-5 |
Catalog # | YR1036 |
Price | please inquire |
Order / More Info | RSV, Respiratory syncytial Virus (Palivizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |